Leukotriene B4 as a Potential Therapeutic Target for the Treatment of Metabolic Disorders
dc.contributor.author | Filgueiras, Luciano Ribeiro | |
dc.contributor.author | Serezani, C. Henrique | |
dc.contributor.author | Jancar, Sonia | |
dc.contributor.department | Department of Microbiology & Immunology, IU School of Medicine | en_US |
dc.date.accessioned | 2016-10-06T18:48:48Z | |
dc.date.available | 2016-10-06T18:48:48Z | |
dc.date.issued | 2015-10-08 | |
dc.identifier.citation | Filgueiras, L. R., Serezani, C. H., & Jancar, S. (2015). Leukotriene B4 as a Potential Therapeutic Target for the Treatment of Metabolic Disorders. Frontiers in Immunology, 6, 515. http://doi.org/10.3389/fimmu.2015.00515 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/11122 | |
dc.language.iso | en_US | en_US |
dc.publisher | Frontiers Media | en_US |
dc.relation.isversionof | 10.3389/fimmu.2015.00515 | en_US |
dc.relation.journal | Frontiers in Immunology | en_US |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | |
dc.source | PMC | en_US |
dc.subject | Diabetes | en_US |
dc.subject | Leukotriene B4 | en_US |
dc.subject | Insulin resistance | en_US |
dc.subject | Metabolic disorders | en_US |
dc.subject | Sterile inflammation | en_US |
dc.title | Leukotriene B4 as a Potential Therapeutic Target for the Treatment of Metabolic Disorders | en_US |
dc.type | Article | en_US |